- Contemporary management of borderline resectable pancreatic ductal adenocarcinoma
-
Lekka K, Tzitzi E, Giakoustidis A, Papadopoulos V, Giakoustidis D
- KMID: 2448761
- Ann Hepatobiliary Pancreat Surg.
- 2019 May;23(2):97-108.
- doi: 10.14701/ahbps.2019.23.2.97
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive tumors, with a low rate of survival, likely due to the tendency of the tumor for early local and distant... -
- CITED
-
- Close
- SHARE
-
- Close
- Primary gigantic leiomyosarcoma of the liver treated with portal vein embolization and liver resection
-
Giakoustidis D, Giakoustidis A, Goulopoulos T, Arabatzi N, Kainantidis A, Zaraboukas T
- KMID: 2397804
- Ann Hepatobiliary Pancreat Surg.
- 2017 Nov;21(4):228-231.
- doi: 10.14701/ahbps.2017.21.4.228
Primary hepatic leiomyosarcoma (PHL) is an extremely rare tumor. The tumor has no specific presentations and often diagnosis is delayed until it reaches a significant size. We report the case... -
- CITED
-
- Close
- SHARE
-
- Close
- Identifying the role of neutrophil-to-lymphocyte ratio and platelets-to-lymphocyte ratio as prognostic markers in patients undergoing resection of pancreatic ductal adenocarcinoma
-
Giakoustidis A, Neofytou K, Costa Neves M, Giakoustidis D, Louri E, Cunningham D, Mudan S
- KMID: 2420608
- Ann Hepatobiliary Pancreat Surg.
- 2018 Aug;22(3):197-207.
- doi: 10.14701/ahbps.2018.22.3.197
BACKGROUNDS/AIMS: It is important to point out that the identification of inflammation is an essential component of the pathogenesis and the progression of cancer. In this study, we analysed the... -
- CITED
-
- Close
- SHARE
-
- Close
